Pinz Capital Management, LP Krystal Biotech, Inc. Transaction History

Pinz Capital Management, LP

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	SELL	$51.99 - $72.11 $233,955 - $324,495	-4,500 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$39.81 - $88.24 $179,145 - $397,080	4,500 New	4,500 $315,000
Q3 2020 Nov 16, 2020	SELL	$37.76 - $48.49 $702,336 - $901,914	-18,600 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$37.03 - $60.0 $688,758 - $1.12 Million	18,600 New	18,600 $770,000

310

24.4M

483K

364K

Ticker KRYS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 25,664,300
Market Cap $4.89B
Description
Krystal Biotech, Inc., a clinical stage biotechnology company, engages in the field of redosable gene therapy to treat serious rare diseases in the United States. Its lead product candidate is beremagene geperpavec (B-VEC), which is in Phase III clinical study to treat dystrophic epidermolysis bullosa. The company is also involved in developing ...

Get notified when there are updates to the investment portfolio of Pinz Capital Management, LP, based on Form 13F filings with the SEC.

Stay updated on Pinz Capital Management, LP with notifications on news.